United Kingdom

Kaken Pharmaceutical Co Ltd (4521.T)

4521.T on Tokyo Stock Exchange

19 Jun 2018
Change (% chg)

¥-20 (-0.34%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Tetsuo Ohnuma

67 2011 President, Representative Director

Hirokazu Konishi

64 2017 Managing Director

Jun Takaoka

62 2016 Managing Director

Hiroyuki Horiuchi

55 2017 Chief Director of Sales, Director

Jumpei Suzuki

2016 Executive Officer, Director of Accounting